Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology

Anal Biochem. 2004 Jul 1;330(1):98-113. doi: 10.1016/j.ab.2004.02.027.

Abstract

To gauge the experimental variability associated with Biacore analysis, 36 different investigators analyzed a small molecule/enzyme interaction under similar conditions. Acetazolamide (222 g/mol) binding to carbonic anhydrase II (CAII; 30000 Da) was chosen as a model system. Both reagents were stable and their interaction posed a challenge to measure because of the low molecular weight of the analyte and the fast association rate constant. Each investigator created three different density surfaces of CAII and analyzed an identical dilution series of acetazolamide (ranging from 4.1 to 1000 nM). The greatest variability in the results was observed during the enzyme immobilization step since each investigator provided their own surface activating reagents. Variability in the quality of the acetazolamide binding responses was likely a product of how well the investigators' instruments had been maintained. To determine the reaction kinetics, the responses from the different density surfaces were fit globally to a 1:1 interaction model that included a term for mass transport. The averaged association and dissociation rate constants were 3.1+/-1.6 x 10(6)M(-1)s(-1) and 6.7+/-2.5 x 10(-2)s(-1), respectively, which corresponded to an average equilibrium dissociation constant (K(D) of 2.6+/-1.4 x 10(-8)M. The results provide a benchmark of variability in interpreting binding constants from the biosensor and highlight keys areas that should be considered when analyzing small molecule interactions.

MeSH terms

  • Acetazolamide / chemistry*
  • Acetazolamide / metabolism
  • Carbonic Anhydrase II / chemistry*
  • Carbonic Anhydrase II / metabolism
  • Kinetics
  • Observer Variation
  • Protein Binding
  • Research Personnel
  • Surface Plasmon Resonance* / instrumentation
  • Surface Plasmon Resonance* / standards

Substances

  • Carbonic Anhydrase II
  • Acetazolamide